Evidence map›Paper›PMID 21913019›Full record

ArticleAnnals of surgical oncology2012

Clinicopathological significance of BMP7 expression in esophageal squamous cell carcinoma.

Koichi Megumi, Sumiya Ishigami, Yasuto Uchikado, Yoshiaki Kita, Hiroshi Okumura, Masataka Matsumoto, Yoshikazu Uenosono, Takaaki Arigami, Yuko Kijima, Masaki Kitazono and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Annals of surgical oncology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. High BMP7 expression is associated with poor prognosis in ovarian cancer.Journal of cellular and molecular medicine · 2023
    Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. CD109 and squamous cell carcinoma.Journal of translational medicine · 2018
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Koichi MegumiDepartment of Surgical Oncology, Digestive Surgery, Kagoshima University, Graduate School of Medicine, Kagoshima, Japan. aircarter@goo.jp
Sumiya Ishigami
Yasuto Uchikado
Yoshiaki Kita
Hiroshi Okumura
Masataka Matsumoto
Yoshikazu Uenosono
Takaaki Arigami
Yuko Kijima
Masaki Kitazono
Hiroyuki Shinchi
Shinichi Ueno
Shoji Natsugoe
Kagoshima University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBone morphogenetic proteins (BMPs) are secreted signaling molecules belonging to the transforming growth factor-β (TGF-β) superfamily of growth factors. Recent studies have shown that the influence of the expression of BMP7 was altered in several tumors. The purpose of the current study was to examine the expression of BMP7 in esophageal squamous cell carcinoma and to clarify the clinical impact of BMP7 expression in esophageal squamous cell carcinoma (ESCC).

methodsA total of 180 patients with ESCC who underwent surgical resection from 1991 to 2004 were eligible for this study. The expression of BMP7 in esophageal tumor tissues was examined immunohistochemically.

resultsBMP7 expression was found in the cytoplasm of cancer cells. BMP7 positivity was observed in 61.7% of tumors. The BMP7-positive group had deeper progression, more advanced stages, and greater venous invasion than those without BMP7 expression (p < 0.001, p < 0.005, and p < 0.0005, respectively). In addition, expression of BMP7 correlated with poorer prognosis (p < 0.0005). Multivariate analysis showed that BMP7 expression status was an independent prognostic factor (p < 0.05).

conclusionsPatients with expression of BMP7 in ESCC had high malignant potential. BMP7 could be a useful prognostic marker for patients with ESCC.

Indexed as

AdultAgedAged, 80 and overBiomarkers, TumorBone Morphogenetic Protein 7Carcinoma, Squamous CellDisease ProgressionEsophageal NeoplasmsFemaleFollow-Up StudiesHumansImmunoenzyme TechniquesLymphatic MetastasisMaleMiddle AgedNeoplasm InvasivenessBiomarkers, TumorBone Morphogenetic Protein 7

Identifiers

PMID21913019
PMCPMC3356521
OpenAlexW2013782861

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.